J0217 HCPCS Level II code: Injection, velmanase alfa-tycv, 1 mg
J0217 is the HCPCS code for “Injection, velmanase alfa-tycv, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0217Injection, velmanase alfa-tycv, 1 mg
Short description: Inj velmanase alfa-tycv 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0217 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2024
Where J0217 sits
- 1J codesDrugs administered other than orally
- 2Active code J0217Injection, velmanase alfa-tycv, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0217 mean?
J0217 is the HCPCS code for “Injection, velmanase alfa-tycv, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0217?
CMS lists J0217’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0217
All J codesJ0208Injection, sodium thiosulfate (pedmark), 100 mgJ0209Injection, sodium thiosulfate (hope), 100 mgJ0210Injection, methyldopate hcl, up to 250 mgJ0211Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)J0215Injection, alefacept, 0.5 mgJ0216Injection, alfentanil hydrochloride, 500 microgramsJ0218Injection, olipudase alfa-rpcp, 1 mgJ0219Injection, avalglucosidase alfa-ngpt, 4 mgJ0220Injection, alglucosidase alfa, 10 mg, not otherwise specifiedJ0221Injection, alglucosidase alfa, (lumizyme), 10 mgJ0222Injection, patisiran, 0.1 mgJ0223Injection, givosiran, 0.5 mg